Association of Serum Vitamin D-binding Protein with Components of Metabolic Syndrome in Type 2 Diabetic Patients in Gorgan | ||||
| Bulletin of Pharmaceutical Sciences Assiut University | ||||
| Articles in Press, Accepted Manuscript, Available Online from 21 January 2024 | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/bfsa.2024.216659.1774 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Abdoljalal Marjani  1; Safa Jalal Abdalsahib Alhasoon1; Karrar Jaber Hasan Al-hajmee1; Mojtaba Zare Ebrahimabad1; Taghi Amiriani2
| ||||
| 1Metabolic Disorders Research Center, Department of Biochemistry and Biophysics, Gorgan Faculty of Medicine, Golestan University of Medical Sciences, Golestan Province, Gorgan, Iran | ||||
| 2Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Golestan Province, Gorgan, Iran | ||||
| Abstract | ||||
| The metabolic syndrome (MetS) is an important problem in the development of several disorders. Variations in Vitamin D binding protein (VDBP) may affect insulin secretion and glucose metabolism. This study was conducted to assess serum VDBP between MetS subjects and Type 2 diabetes mellitus (T2DM), and without MetS subjects and its association with MetS components, in Gorgan. 243 patients of T2DM were included in this study. 81 patients with MetS and vitamin D deficiency (group1), 81 patients with MetS and normal vitamin D level (group2) and 81 subjects without MetS and normal vitamin D level (group3). Adult Treatment Panel-III (ATP-III) guidelines are used to define the MetS subjects. Serum VDBP levels were significantly lower in the MetS subjects than the subjects without MetS. The triglyceride (TG) and fasting blood glucose (FBG) levels were significantly lower and higher in subjects with MetS and normal vitamin D when compared to subjects with MetS, and vitamin D deficiency. Serum VDBP levels were significantly lower in MetS subjects and vitamin D deficiency compared to subjects without MetS and normal vitamin D. There were positive and negative correlations between VDBP and FBG and TG in groups 1 and 2. It could be concluded that controlling of VDBP is an effective way for controlling MetS components in subjects with MetS. It suggests that the estimation of VDBP level in different populations appears to play an important role in evaluating and considering the relationship between VDBP and MetS components in subjects with MetS. | ||||
| Keywords | ||||
| VDBP; Metabolic syndrome; components; Type 2 diabetes mellitus; Gorgan | ||||
|
Statistics Article View: 61 |
||||
